Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 78 of 1714:
68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88
Gene Compound Assay Inh Ic50 Ki View
phosphodiesterase 3A DICUMAROL Phosphodiesterase PDE3 53% NoneNone NoneNone View
mitogen activated protein kinase 14 MECLOFENAMIC ACID Protein Serine/Threonine Kinase, p38alpha 53% NoneNone NoneNone View
mitogen-activated protein kinase 14 MECLOFENAMIC ACID Protein Serine/Threonine Kinase, p38alpha 53% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 GENISTEIN Dopamine Transporter 53% 16.918uM 13.442uM View
adrenergic receptor, alpha 2a GRANISETRON Imidazoline I2, Central 53% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) GRANISETRON Imidazoline I2, Central 53% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ISOTRETINOIN Adrenergic, Norepinephrine Transporter 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit GUANFACINE Calcium Channel Type L, Phenylalkylamine 53% NoneNone NoneNone View
opioid receptor, sigma 1 LYSERGOL Sigma1 53% NoneNone NoneNone View
opioid receptor, kappa 1 MEPAZINE Opiate kappa 53% NoneNone NoneNone View
cannabinoid receptor 1 (brain) LORATADINE Cannabinoid CB1 53% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 4,4'-METHYLENEDIANILINE Cyclooxygenase COX-1 53% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) 4,4'-METHYLENEDIANILINE Cyclooxygenase COX-1 53% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) LOPERAMIDE Adrenergic alpha1D 53% NoneNone NoneNone View
adrenergic receptor, alpha 2b 1-NAPHTHYL ISOTHIOCYANATE Adrenergic alpha2C 53% 54.539uM 7.924uM View
adrenergic receptor, alpha 2c (Non-specific probe) 1-NAPHTHYL ISOTHIOCYANATE Adrenergic alpha2C 53% 54.539uM 7.924uM View
5-hydroxytryptamine (serotonin) receptor 2A MITOTANE Serotonin 5-HT2A 53% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C MITOTANE Serotonin 5-HT2C 53% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A TROPISETRON Serotonin 5-HT2A 53% NoneNone NoneNone View
Sigma-2 Receptor SELEGILINE Sigma2 53% NoneNone NoneNone View
Protein-tyrosine kinase, Fyn SERTRALINE Protein Tyrosine Kinase, Fyn 53% NoneNone NoneNone View
dopamine receptor D4 NORTRIPTYLINE Dopamine D4.2 53% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type IV, beta PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type IV, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type III, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type II, beta PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type II, alpha 2 PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type I, beta PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type I, alpha PREGNENOLONE-16ALPHA-CARBONITRILE Sodium Channel, Site 2 53% 24.848uM 22.278uM View
sodium channel, voltage-gated, type IV, beta CLOZAPINE Sodium Channel, Site 2 53% NoneNone NoneNone View
platelet-activating factor receptor AMPIROXICAM Platelet Activating Factor (PAF) 52% NoneNone NoneNone View
thromboxane A synthase 1 PARTHENOLIDE Thromboxane Synthetase 52% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) PARTHENOLIDE Thromboxane Synthetase 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta PRIMAQUINE Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DAUNORUBICIN Sodium Channel, Site 2 52% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a PROCHLORPERAZINE Serotonin 5-HT3 52% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b PROCHLORPERAZINE Serotonin 5-HT3 52% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) PINDOLOL Adrenergic alpha1D 52% NoneNone NoneNone View
adrenergic receptor, alpha 2a GUANETHIDINE Imidazoline I2, Central 52% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) GUANETHIDINE Imidazoline I2, Central 52% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase ETHYNODIOL DIACETATE CYP450-1A2 Inhibition 52% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a GUANABENZ Serotonin 5-HT3 52% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b GUANABENZ Serotonin 5-HT3 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel associated protein 1 S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel associated protein 2 S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta S-(-)-PROPRANOLOL Sodium Channel, Site 2 52% NoneNone NoneNone View
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) TAMOXIFEN Protein Serine/Threonine Phosphatase, Calcineurin PP2B 51% 30.573uM NoneNone View
protein phosphatase 3, catalytic subunit, beta isoform TAMOXIFEN Protein Serine/Threonine Phosphatase, Calcineurin PP2B 51% 30.573uM NoneNone View
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) TAMOXIFEN Protein Serine/Threonine Phosphatase, Calcineurin PP2B 51% 30.573uM NoneNone View
adenosine A1 receptor BISACODYL Adenosine A1 51% NoneNone NoneNone View
phosphodiesterase 3B BENZBROMARONE Phosphodiesterase PDE3 51% NoneNone NoneNone View
phosphodiesterase 3A BENZBROMARONE Phosphodiesterase PDE3 51% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DEXFENFLURAMINE Serotonin Transporter 51% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase DEXTROMETHORPHAN CYP450-2D6 Inhibition 51% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific MC 288769 Phosphodiesterase PDE4 51% 22.409uM NoneNone View
phosphodiesterase 4C, cAMP-specific MC 288769 Phosphodiesterase PDE4 51% 22.409uM NoneNone View
phosphodiesterase 4D MC 288769 Phosphodiesterase PDE4 51% 22.409uM NoneNone View
phosphodiesterase 4B, cAMP specific MC 288769 Phosphodiesterase PDE4 51% 22.409uM NoneNone View
cannabinoid receptor 1 (brain) MC 288769 Cannabinoid CB1 51% 41.129uM 32.47uM View
5-hydroxytryptamine (serotonin) receptor 5B FLAVOXATE Serotonin 5-HT4 51% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 FLAVOXATE Serotonin 5-HT4 51% NoneNone NoneNone View
nuclear receptor subfamily 3, group C, member 1 ESTRIOL Glucocorticoid 51% 39.345uM 17.884uM View
sodium channel, voltage-gated, type IV, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel associated protein 1 R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel associated protein 2 R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha R-(+)-PROPRANOLOL Sodium Channel, Site 2 51% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 MONOBENZONE Dopamine Transporter 51% NoneNone NoneNone View
adenosine A2a receptor ISOTRETINOIN Adenosine A2A 51% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 EPERISONE Calcium Channel Type L, Phenylalkylamine 54% NoneNone NoneNone View
dopamine receptor D3 MIANSERIN Dopamine D3 54% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C IDEBENONE Serotonin 5-HT2C 54% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Serotonin 5-HT6 54% NoneNone NoneNone View
epidermal growth factor receptor LEAD (II) ACETATE Protein Tyrosine Kinase, EGF Receptor 54% NoneNone NoneNone View
adrenergic receptor, alpha 2a TIAPRIDE Imidazoline I2, Central 54% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) TIAPRIDE Imidazoline I2, Central 54% NoneNone NoneNone View
epidermal growth factor receptor ZIRCONIUM(IV) CHLORIDE Protein Tyrosine Kinase, EGF Receptor 54% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type GLICLAZIDE Lipoxygenase 15-LO 54% NoneNone NoneNone View
arachidonate 15-lipoxygenase GLICLAZIDE Lipoxygenase 15-LO 54% NoneNone NoneNone View
arachidonate 15-lipoxygenase GLICLAZIDE Lipoxygenase 15-LO 54% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B TROPISETRON Serotonin 5-HT2B 54% NoneNone NoneNone View
histamine receptor H 2 L-744832 Histamine H2 54% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 L-744832 Chemokine CCR2B 54% NoneNone NoneNone View
Sigma-2 Receptor RISPERIDONE Sigma2 54% NoneNone NoneNone View
adrenergic receptor, alpha 1a KETOTIFEN Adrenergic alpha1A 54% NoneNone NoneNone View
epidermal growth factor receptor SERTRALINE Protein Tyrosine Kinase, EGF Receptor 54% NoneNone NoneNone View
nuclear receptor subfamily 3, group C, member 1 SODIUM ARSENITE Glucocorticoid 54% NoneNone NoneNone View
histamine receptor H 2 OXYBUTYNIN Histamine H2 54% NoneNone NoneNone View
adenosine A1 receptor VALDECOXIB Adenosine A1 54% NoneNone NoneNone View
dopamine receptor D1A BENZETHONIUM CHLORIDE Dopamine D1 54% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B NISOLDIPINE Serotonin 5-HT2B 54% NoneNone NoneNone View
adrenergic receptor, beta 3 TRIBROMSALAN Adrenergic beta3 54% NoneNone NoneNone View
opioid receptor, sigma 1 ESMOLOL Sigma1 54% NoneNone NoneNone View